CD

Carl Brendan Doyle

US Ucb Biopharma Srl: 1 patents #35 of 117Top 30%
Overall (2022): #507,076 of 548,613Top 95%
1
Patents 2022

Issued Patents 2022

Showing 1–1 of 1 patents

Patent #TitleCo-InventorsDate
11518803 Antagonist antibodies that bind to human TGFB1, TGFB2 and to TGFB3 and their use for the treatment of lung fibrosis Helene Bon, Joanne Elizabeth Compson, Kate Louise Dixon, Mark Ellis, Maria Margarida Gouveia Sancho +9 more 2022-12-06